Concepedia

Ronald S. Black

RS

Statistics

Publications

27

Citations

5.5K

H-Index

22

Active since

1978

Affiliations

Pfizer (United States)(Current)

Janssen (United States)

University College London

Brigham and Women's Hospital

Columbia University

Ronald S. Black is an author at Pfizer (United States) specializing in alzheimer disease, medicine, and neurology.

Publications per year

1978–2018

27

Publications

27

Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease

Stephen Salloway, Reisa A. Sperling, Nick C. Fox et al. · New England Journal of Medicine · 2014 · 2K citations · Full text

, , +17

11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study

Juha O. Rinne, David J. Brooks, Martin N. Rossor et al. · The Lancet Neurology · 2010 · 695 citations

, , +17

Effects of Aβ immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease

Nick C. Fox, Ronald S. Black, S. Gilman et al. · Neurology · 2005 · 550 citations

, , +17

Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis

Reisa A. Sperling, Stephen Salloway, David J. Brooks et al. · The Lancet Neurology · 2012 · 510 citations

, , +12

Bapineuzumab for mild to moderate Alzheimer’s disease in two global, randomized, phase 3 trials

Rik Vandenberghe, Juha O. Rinne, Merçé Boada et al. · Alzheimer s Research & Therapy · 2016 · 299 citations · Full text

, , +17

1–5 of 27